Acta Clinica Belgica最新文献

筛选
英文 中文
A case of transient lymphangiectasis of the penis. 阴茎暂时性淋巴管扩张1例。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-05-20 DOI: 10.1179/2295333714Y.0000000028
A Misson, A C Deswysen, D Tennstedt, X Muschart
{"title":"A case of transient lymphangiectasis of the penis.","authors":"A Misson,&nbsp;A C Deswysen,&nbsp;D Tennstedt,&nbsp;X Muschart","doi":"10.1179/2295333714Y.0000000028","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000028","url":null,"abstract":"<p><strong>Objective and importance: </strong>Physicians are likely to encounter patients with penis disorders and can be caught off guard by these uncommon pathologies, especially because they occur in a sensitive anatomical location.</p><p><strong>Clinical presentation: </strong>Here, we report the case of a patient presenting with benign transient lymphangiectasis of the penis (BTLP), including its differential diagnosis and treatment. Conclusion headings: BTLP is not an uncommon pathology and diagnosis is based only on medical history and clinical examination. The differentiation between Mondor's disease and BTLP is not necessary for treatment.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"294-5"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32355112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An unexpected complication of bacillus Calmette-Guérin therapy. 卡介苗-谷氨酰胺治疗的意外并发症。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-05-20 DOI: 10.1179/2295333714Y.0000000032
H Yildiz, G Colin, M Lambert
{"title":"An unexpected complication of bacillus Calmette-Guérin therapy.","authors":"H Yildiz,&nbsp;G Colin,&nbsp;M Lambert","doi":"10.1179/2295333714Y.0000000032","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000032","url":null,"abstract":"A 78-year-old man presented with a history of fever and night sweats of 1-month duration. His relevant medical history was a transitional-cell bladder cancer treated with intravesical instillation of bacillus Calmette–Guérin (BCG) 5 months previously. Abdominal palpation revealed a pulsatile mass in the left lower quadrant. Laboratory tests only showed an elevated C-reactive protein at 5.7 mg/dl. Contrast-enhanced CT scan of the abdomen demonstrated a saccular aneurysm of the infra-renal aorta (Fig. 1) suggestive of mycotic aneurysm. An aneurysmal resection was then performed. Aerobic and anaerobic culture of the aortic tissue remained negative but a Ziehl–Nielsen stain was positive consistent with a mycobacterial infection. Acid-fast culture and PCR were positive for Mycobacterium bovis. The diagnosis of mycotic aneurysma following intravesical BCG therapy was then retained. Vascular complications after intravesical instillation of BCG, a live attenuated strain of Mycobacterium bovis, are extremely rare. Haematogenous or lymphatic spread is the most common hypothesis proposed to explain an arterial infection by M. bovis. Both medical and surgical approach are requested in the management of BCGinduced mycotic aneurysm. A combination with at least three antituberculous agents for 9–12 months is recommended. Pyrazinamide should not be used due to widespread resistance of M. bovis.","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"312"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000032","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32355113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Bluish vomiting: a rare clinical presentation of poisoning. 蓝色呕吐:中毒的罕见临床表现。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-05-20 DOI: 10.1179/2295333714Y.0000000033
J Higny, D Vanpee, C Boulouffe
{"title":"Bluish vomiting: a rare clinical presentation of poisoning.","authors":"J Higny,&nbsp;D Vanpee,&nbsp;C Boulouffe","doi":"10.1179/2295333714Y.0000000033","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000033","url":null,"abstract":"<p><p>Bluish vomiting is a symptom of poisoning that is rarely seen in Western emergency departments. Consequently, physicians are not aware of the diagnosis, complications, and treatment of this unusual form of intoxication. In this article, we report a case of bluish vomiting that occurred after an accidental ingestion of copper sulphate. In the discussion, we review three life-threatening causes of bluish vomiting (copper sulphate, boric acid, and paraquat ingestion), and we discuss their respective clinical manifestations, specificities, complications, and management therapies. </p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"299-301"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32356512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Laboratory diagnosis of schistosomiasis and Katayama syndrome in returning travellers. 返国旅行者血吸虫病和片山综合征的实验室诊断。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-06-10 DOI: 10.1179/2295333714Y.0000000039
B Van Meensel, E Van Wijngaerden, J Verhaegen, W E Peetermans, M L Lontie, C Ripert
{"title":"Laboratory diagnosis of schistosomiasis and Katayama syndrome in returning travellers.","authors":"B Van Meensel,&nbsp;E Van Wijngaerden,&nbsp;J Verhaegen,&nbsp;W E Peetermans,&nbsp;M L Lontie,&nbsp;C Ripert","doi":"10.1179/2295333714Y.0000000039","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000039","url":null,"abstract":"<p><p>The gold standard for laboratory diagnosis of schistosomiasis is the presence of typical eggs in stool or urine. The laboratory diagnosis of schistosomiasis and Katayama syndrome in returning travellers is difficult because the number of excreted eggs is often very limited. In early infections and in patients with only a few contacts with contaminated water, the total number of parasites, migrating larvae or schistosomulae, and adult worms, is very low. Eggs can only be found in faeces or urine when there is at least one pair of adult worms at the final location. The number of parasites increases as a function of the number of contacts with infected water. The exact latency between contamination and egg production is unknown. It is estimated that excretion of eggs starts after 40-50 days. The specific diagnosis of early schistosomiasis and Katayama fever relies essentially on serologic tests or preferably on PCR (if available). These assays are much more sensitive (up to four times) in the early phase of schistosomiasis than microscopic examination for typical eggs. Eosinophilia (sometimes exceeding 50%) is often present in patients with acute schistosomiasis (Katayama fever), but may be limited or absent in late fibrotic manifestations of the disease. </p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"267-72"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32411839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Thoracopulmonary actinomycosis, a case report of a 42-year-old man with coughing and a bump in his right axilla. 胸肺放线菌病,报告一例42岁男性咳嗽及右腋窝肿块。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-06-10 DOI: 10.1179/2295333714Y.0000000014
C B Seghers, I Stappaerts
{"title":"Thoracopulmonary actinomycosis, a case report of a 42-year-old man with coughing and a bump in his right axilla.","authors":"C B Seghers,&nbsp;I Stappaerts","doi":"10.1179/2295333714Y.0000000014","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000014","url":null,"abstract":"<p><p>The diagnosis of thoracopulmonary actinomycosis is challenging because it is a rare disease, symptoms are aspecific and can mimic a lot of other lung pathologies. Especially the differential diagnosis with pulmonary tuberculosis is difficult because clinical symptoms are often very similar. We present a case of thoracopulmonary abcedating actinomycosis in a young immunocompetent man with no predisposing illness. He was initially treated for pulmonary tuberculosis. He showed good response to IV penicillin, which was later switched to oral amoxicillin when he went home. </p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"287-9"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32411835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postprandial reactive hypoglycaemia in a very old patient. 高龄患者餐后反应性低血糖1例。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-06-10 DOI: 10.1179/2295333714Y.0000000026
C Deliens, Cl Losseau, B Vandeleene, B Boland
{"title":"Postprandial reactive hypoglycaemia in a very old patient.","authors":"C Deliens,&nbsp;Cl Losseau,&nbsp;B Vandeleene,&nbsp;B Boland","doi":"10.1179/2295333714Y.0000000026","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000026","url":null,"abstract":"<p><strong>Objective and importance: </strong>Postprandial reactive hypoglycaemia (PRH) is a clinical syndrome characterized by the recurrence of symptomatic hypoglycaemia during postprandial periods. PRH remains a diagnostic challenge for clinicians, because of its atypical manifestations and low prevalence, especially in older persons.</p><p><strong>Clinical presentation: </strong>We report the diagnostic work-up of severe hypoglycaemic episodes in a very old patient in whom the diagnosis of PRH was made.</p><p><strong>Intervention: </strong>We prescribed acarbose, an alpha-glucosidase inhibitor, to this patient to prevent the recurrence of hypoglycaemic episodes. Four years later, acarbose was always used and no further episode of hypoglycaemia had occurred. Based on the literature, we discuss the limited value of endocrine tests as well as the efficacy of the therapeutic approaches.</p><p><strong>Conclusion: </strong>Prescription of acarbose is useful in addition to nutritional education, the corner stone of the treatment, to avoid the recurrence of severe hypoglycaemic events due to PRH.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"290-3"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32411837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Muscle metastasis from non-small cell lung cancer: two cases and literature review. 非小细胞肺癌肌肉转移2例并文献复习。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 Epub Date: 2014-05-29 DOI: 10.1179/2295333714Y.0000000035
Y Tezcan, M Koc
{"title":"Muscle metastasis from non-small cell lung cancer: two cases and literature review.","authors":"Y Tezcan,&nbsp;M Koc","doi":"10.1179/2295333714Y.0000000035","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000035","url":null,"abstract":"<p><p>Non-small cell lung cancers (NSCLC) is the most commonly observed group among lung cancers. Adenocancers are histopathologically more common. Males are more affected than females, an effect which is directly related to smoking. They generally cause distant haematogenous and lymphatic metastasis. Distant haematogenous metastases are often seen in contralateral lung, brain, bone, adrenals, and liver. Muscle metastases from NSCLC are quite rare and male cases are more frequently affected compared to female cases. NSCLC cases with muscle metastasis are at the same time accompanied by distant organ metastases such as bone, brain, and liver. All treatment approaches are considered to be palliative in these cases, which are symptomatologically quite severe. In the present study, we presented the rarely observed cases of two male patients with muscle metastasis from NSCLC together with the related literature. </p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"302-4"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32374746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease? behet病患者血清血管抑制素水平:血管生成在behet病的发病机制中起作用吗?
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-08-01 DOI: 10.1179/2295333714Y.0000000030
D Keskin, G Keskin, A Inal, L Ozışık
{"title":"Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?","authors":"D Keskin,&nbsp;G Keskin,&nbsp;A Inal,&nbsp;L Ozışık","doi":"10.1179/2295333714Y.0000000030","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000030","url":null,"abstract":"<p><p>Angiogenesis plays an important role in the pathogenesis of inflammatory diseases, but the possible role of angiogenesis in Behçet's disease (BD) has not yet been studied. The aim of this study was to determine angiostatin levels in patients with BD and the role of angiogenesis in the pathogenesis of the disease. Thirty-seven patients with BD (mean age: 28·6±5·4 years, mean disease duration: 9·3±3·7 years) and 18 healthy controls were enrolled to the study. Twenty-four patients were in active and 13 patients were in inactive stage of the disease. The mean serum angiostatin level of patients with BD was 113·9±53·2 and 60·7±20·1 ng/ml in healthy controls. The mean serum angiostatin level was 142·7±43·1 ng/ml in active and 86·9±15·5 ng/ml in inactive patients with BD. Serum angiostatin levels were significantly high in patients with BD compared with healthy controls (P<0·001) and it was significantly high in active patients compared with inactive patients with BD (P<0·001). In inactive patients with BD, serum angiostatin concentrations were found to be higher compared with healthy controls (P<0·01). In active BD patients, the mean serum angiostatin level was correlated with the deep vein thrombosis (r = 0·482, P = 0·05), uveitis (r = 0·582, P = 0·01), and arthritis (r = 0·492, P = 0·05). According to these results; elevated serum angiostatin levels in patients with BD suggest the possible role of angiogenesis in the pathogenesis of the disease and its high levels in inactive Behçet's patients is related with the continuous activation of the disease even in the subclinical period. </p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 4","pages":"246-50"},"PeriodicalIF":1.6,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000030","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32496095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
HIV disclosure in the workplace. 在工作场所披露艾滋病毒。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-06-01 Epub Date: 2014-03-13 DOI: 10.1179/2295333714Y.0000000013
S Degroote, D Vogelaers, R Koeck, R Borms, L De Meulemeester, D Vandijck
{"title":"HIV disclosure in the workplace.","authors":"S Degroote,&nbsp;D Vogelaers,&nbsp;R Koeck,&nbsp;R Borms,&nbsp;L De Meulemeester,&nbsp;D Vandijck","doi":"10.1179/2295333714Y.0000000013","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000013","url":null,"abstract":"<p><strong>Objectives: </strong>As HIV is currently a chronic and manageable disease, an increasing amount of people living with HIV (PLHIV) are (again) active on the labour market. Since research on this topic is scarce, this study aimed to explore experiences of PLHIV in the workplace, especially concerning disclosure and adherence to antiretroviral therapy.</p><p><strong>Methods: </strong>A questionnaire was developed and validated in collaboration with Sensoa (Flemish expertise centre for sexual health) and participants were recruited using flyers and announcements on websites.</p><p><strong>Results: </strong>A total of 54 PLHIV completed the questionnaire, among whom 50 (92·6%) males. Half of the participants did not disclose their HIV status in the workplace, mostly due to being afraid of social or professional consequences. Those who disclosed, reported no changes in the workplace or even reported receiving more empathy. A minority of participants have to take antiretroviral medication at work and they reported no particular problems related to medication intake.</p><p><strong>Conclusion: </strong>Despite improved solidarity and information campaigns, many PLHIV still do not disclose their HIV status in the workplace, most frequently due to fear for discrimination. More actions are warranted, as well as addressing possible self-stigma. Adherence to antiretroviral therapy in the workplace posed little or no problems.</p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 3","pages":"191-3"},"PeriodicalIF":1.6,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32335161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Survival of patients with metastatic breast cancer: a single-centre experience. 转移性乳腺癌患者的生存:单中心经验。
IF 1.6 4区 医学
Acta Clinica Belgica Pub Date : 2014-06-01 Epub Date: 2014-03-18 DOI: 10.1179/2295333714Y.0000000016
R D'hondt, I Spoormans, N Neyens, N Mortier, F Van Aelst
{"title":"Survival of patients with metastatic breast cancer: a single-centre experience.","authors":"R D'hondt,&nbsp;I Spoormans,&nbsp;N Neyens,&nbsp;N Mortier,&nbsp;F Van Aelst","doi":"10.1179/2295333714Y.0000000016","DOIUrl":"https://doi.org/10.1179/2295333714Y.0000000016","url":null,"abstract":"<p><p>Metastatic breast cancer (MBC) remains an incurable disease, despite major advances in the treatment in the past 10-12 years. Data on real life overall survival in a non-selected group containing all metastatic breast cancer patients are hard to find in the literature, as is the correlation of their survival with prognostic factors and treatment. This article provides overall survival data for all patients treated for MBC in a single-centre non-academic hospital. Survival data have been correlated with frequently used prognostic factors (subtype, age at diagnosis, M-status at diagnosis, metastases-free interval, and grade). It also gives an insight in the treatments given to and response rates in this population of MBC patients without selection bias representing the real life situation. A total of 169 patients were analysed. Mean survival from metastases is 31·8 months. Overall survival is better for the luminal subtypes, for younger age, for patients with a longer metastases-free interval, and for a lower grade. A small difference in survival has been seen in favour of the patients who represent immediately with metastases. With a larger sample size, we expect these factors to be prognostic significant. The luminal subtypes have a clear predisposition to metastasize in the bone, whereas visceral metastases occur more frequently and earlier in the hormone receptor-negative tumours. Brain metastases do occur in about half of the triple negative tumours and Her2/neu-positive tumours. Overall response rate to first-line chemotherapy was 56% in consecutive lines of treatment, a continuous clinical benefit exceeding 50% when selecting fit patients. This article represents a unique and valuable description of medical oncologists' real-life daily practice in MBC patients, with a clinical outcome that certainly compares to the sparse data provided in the literature. </p>","PeriodicalId":48865,"journal":{"name":"Acta Clinica Belgica","volume":"69 3","pages":"194-9"},"PeriodicalIF":1.6,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/2295333714Y.0000000016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32184734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信